Advantages of prophylactic versus conventionally scheduled heart failure therapy in an experimental model of doxorubicin-induced cardiomyopathy.

Mária LódiDániel PrikszGábor Áron FülöpBeáta BódiAlexandra GyöngyösiLilla NagyÁrpád KovácsAttila Béla KertészJudit KocsisIstván ÉdesZoltán CsanádiIstván CzurigaZoltán KisvárdayBéla JuhászIstván LekliPéter BaiAttila TóthZoltán PappDaniel Czuriga

Published in: Journal of translational medicine (2019)

For attenuating DOX-induced adverse myocardial effects, prophylactic cardioprotection has many advantages compared to a late-applied treatment.

Keyphrases

heart failure
high glucose
diabetic rats
left ventricular
drug induced
oxidative stress
drug delivery
stem cells
atrial fibrillation
emergency department
cardiac resynchronization therapy
combination therapy